SMBC Venture Capital

RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.

EX-Fusion is focused on developing and operating the world's first laser-powered commercial nuclear fusion reactor, aiming to provide sustainable energy solutions. The company specializes in manufacturing continuous plasma generators and offers technology for fusion systems, alongside conducting laser-plasma research. This initiative addresses the limitations of traditional government-funded fusion research, which often faces delays due to political and budgetary constraints. By pursuing an independent approach to fusion technology, EX-Fusion seeks to advance the practical application of laser fusion reactors, potentially revolutionizing the energy sector.

Kyoto Fusioneering is a privately funded technology start-up established in 2019 and based in Kyoto, Japan. The company specializes in developing advanced technologies for commercial fusion reactors, including gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. By providing innovative solutions such as liquid metal and molten salt systems, as well as tritium treatment and high-frequency microwave gyrotrons, Kyoto Fusioneering aims to support both public and private fusion developers globally. The company's efforts contribute to the acceleration of fusion energy as a sustainable and carbon-free power source for the future.